JP2002542281A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002542281A5 JP2002542281A5 JP2000613414A JP2000613414A JP2002542281A5 JP 2002542281 A5 JP2002542281 A5 JP 2002542281A5 JP 2000613414 A JP2000613414 A JP 2000613414A JP 2000613414 A JP2000613414 A JP 2000613414A JP 2002542281 A5 JP2002542281 A5 JP 2002542281A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- prevention
- treatment
- pharmaceutical composition
- depression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 208000020401 Depressive disease Diseases 0.000 description 2
- 208000020925 Bipolar disease Diseases 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 208000012826 adjustment disease Diseases 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000024732 dysthymic disease Diseases 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9905338A FR2792835B3 (fr) | 1999-04-27 | 1999-04-27 | Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression |
| FR99/05338 | 1999-04-27 | ||
| PCT/FR2000/001084 WO2000064423A2 (fr) | 1999-04-27 | 2000-04-25 | Utilisation du saredutant et de ses sels pharmaceutiquement acceptables dans le traitement ou la prevention des troubles de l'humeur d'adaptation et de l'anxiete-depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002542281A JP2002542281A (ja) | 2002-12-10 |
| JP2002542281A5 true JP2002542281A5 (enExample) | 2006-01-19 |
Family
ID=9544931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000613414A Pending JP2002542281A (ja) | 1999-04-27 | 2000-04-25 | あらゆる気分障害、適応障害または不安−抑うつ混合障害の治療または予防に有用な医薬の調製のためのサレドゥタントおよび医薬として許容されるその塩類の使用 |
Country Status (32)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2792835B3 (fr) * | 1999-04-27 | 2001-05-25 | Sanofi Sa | Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression |
| WO2001077069A1 (en) * | 2000-04-06 | 2001-10-18 | Astrazeneca Ab | Naphthamide neurokinin antagonists for use as medicaments |
| ATE400563T1 (de) * | 2000-04-06 | 2008-07-15 | Astrazeneca Ab | Neue neurokinin-antagonisten zum gebrauch als arzneimittel |
| US6846814B2 (en) | 2000-04-06 | 2005-01-25 | Astra Zeneca Ab | Neurokinin antagonists for use as medicaments |
| US6903092B2 (en) | 2000-04-06 | 2005-06-07 | Peter Bernstein | Naphthamide neurokinin antagonists for use as medicaments |
| GB0019008D0 (en) * | 2000-08-04 | 2000-09-27 | Astrazeneca Ab | Therapeutic compounds |
| SE0003476D0 (sv) | 2000-09-28 | 2000-09-28 | Astrazeneca Ab | Compounds |
| FR2904221B1 (fr) * | 2006-07-31 | 2008-09-12 | Sanofi Aventis Sa | Composition pharmaceutique contenant en association le saredutant et la fluoxetine. |
| FR2912057B1 (fr) * | 2007-02-07 | 2009-04-17 | Sanofi Aventis Sa | Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine |
| TW200817003A (en) * | 2006-07-31 | 2008-04-16 | Sanofi Aventis | Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor |
| FR2912058A1 (fr) * | 2007-02-07 | 2008-08-08 | Sanofi Aventis Sa | Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles |
| ES2382415T3 (es) * | 2007-09-14 | 2012-06-08 | F. Hoffmann-La Roche Ag | Derivados de piperidina como antagonistas de receptores de NK3 |
| US20090076083A1 (en) * | 2007-09-19 | 2009-03-19 | Protia, Llc | Deuterium-enriched saredutant |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical compositions containing them |
| FR2695626B1 (fr) * | 1992-09-17 | 1994-12-02 | Lebroch Yannick | Dispositif de gobelet adaptable sur un conteneur de boisson. |
| FR2696178B1 (fr) * | 1992-09-30 | 1994-12-30 | Sanofi Elf | Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant. |
| FR2700472B1 (fr) * | 1993-01-19 | 1995-02-17 | Rhone Poulenc Rorer Sa | Association synergisante ayant un effet antagoniste des récepteurs NK1 et NK2. |
| US5512680A (en) * | 1993-02-26 | 1996-04-30 | Sanofi | Process for the preparation of an optically pure aminoalcohol |
| IL112778A0 (en) * | 1994-03-04 | 1995-05-26 | Merck & Co Inc | Substituted heterocycles, their preparation and pharmaceutical compositions containing them |
| US5554644A (en) * | 1994-06-08 | 1996-09-10 | Warner-Lambert Company | Tachykinin (NK2) antagonists |
| FR2792835B3 (fr) * | 1999-04-27 | 2001-05-25 | Sanofi Sa | Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression |
-
1999
- 1999-04-27 FR FR9905338A patent/FR2792835B3/fr not_active Expired - Fee Related
-
2000
- 2000-04-25 HU HU0200969A patent/HUP0200969A3/hu unknown
- 2000-04-25 SK SK1547-2001A patent/SK285459B6/sk not_active IP Right Cessation
- 2000-04-25 NZ NZ513851A patent/NZ513851A/xx not_active IP Right Cessation
- 2000-04-25 BR BR0010006-4A patent/BR0010006A/pt not_active Application Discontinuation
- 2000-04-25 JP JP2000613414A patent/JP2002542281A/ja active Pending
- 2000-04-25 EE EEP200100553A patent/EE05211B1/xx not_active IP Right Cessation
- 2000-04-25 UA UA2001096123A patent/UA69441C2/uk unknown
- 2000-04-25 WO PCT/FR2000/001084 patent/WO2000064423A2/fr not_active Ceased
- 2000-04-25 AT AT00922735T patent/ATE234617T1/de active
- 2000-04-25 US US09/958,439 patent/US6573281B1/en not_active Expired - Fee Related
- 2000-04-25 TR TR2001/02512T patent/TR200102512T2/xx unknown
- 2000-04-25 CZ CZ20013812A patent/CZ294904B6/cs not_active IP Right Cessation
- 2000-04-25 RU RU2001124802/14A patent/RU2238726C2/ru not_active IP Right Cessation
- 2000-04-25 AU AU43034/00A patent/AU764304B2/en not_active Ceased
- 2000-04-25 DE DE60001725T patent/DE60001725T2/de not_active Expired - Lifetime
- 2000-04-25 PT PT00922735T patent/PT1173179E/pt unknown
- 2000-04-25 MX MXPA01010904A patent/MXPA01010904A/es active IP Right Grant
- 2000-04-25 DK DK00922735T patent/DK1173179T3/da active
- 2000-04-25 CA CA002370834A patent/CA2370834C/en not_active Expired - Fee Related
- 2000-04-25 SI SI200030071T patent/SI1173179T1/xx unknown
- 2000-04-25 CN CNB008066817A patent/CN1172669C/zh not_active Expired - Fee Related
- 2000-04-25 ES ES00922735T patent/ES2193065T3/es not_active Expired - Lifetime
- 2000-04-25 KR KR1020017013704A patent/KR20020001850A/ko not_active Ceased
- 2000-04-25 IL IL14526900A patent/IL145269A0/xx not_active IP Right Cessation
- 2000-04-25 PL PL351922A patent/PL196479B1/pl not_active IP Right Cessation
- 2000-04-25 EP EP00922735A patent/EP1173179B1/fr not_active Expired - Lifetime
- 2000-04-26 AR ARP000101955A patent/AR023597A1/es unknown
- 2000-05-10 TW TW089107876A patent/TWI225399B/zh not_active IP Right Cessation
-
2001
- 2001-08-29 ZA ZA200107143A patent/ZA200107143B/xx unknown
- 2001-09-28 BG BG105962A patent/BG65472B1/bg unknown
- 2001-10-25 NO NO20015228A patent/NO20015228L/no not_active Application Discontinuation
-
2003
- 2003-04-08 US US10/409,504 patent/US7390823B2/en not_active Expired - Fee Related
-
2008
- 2008-05-21 US US12/124,262 patent/US20080227818A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2025027I1 (no) | Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget. | |
| WO2004066910A8 (en) | Controlled release modifying complex and pharmaceutical compositions thereof | |
| WO2003015779A3 (de) | Matrixkontrolliertes transdermales therapeutisches system zur anwendung von pramipexol und ropinirol | |
| JP2002542281A5 (enExample) | ||
| WO2002019969A3 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
| EP1232757A4 (en) | MEDICINE FOR DISEASES ASSOCIATED WITH LOSS OF BONE SUBSTANCE | |
| SI1546127T1 (sl) | Novi pirimidinamidni derivati in njihova uporaba | |
| MX2007015480A (es) | Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada. | |
| NO20013060D0 (no) | Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff | |
| ATE262893T1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| EA201101119A1 (ru) | Дозируемая форма, содержащая пантопразол в качестве активного ингредиента | |
| CA2370834A1 (en) | Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders | |
| MXPA03000439A (es) | Nueva forma de (r)-n-(5-metil -8-(4-metilpiperazin -1-il) -1,2,3,4-tetrahidro-2-naftil) -4-morfolinobenzamida. | |
| NO20031410L (no) | Anvendelse av distamycinderivater for fremstilling av medikamenter | |
| WO2004098577A3 (en) | Dosage form containing (s)-pantoprazole as active ingredient | |
| WO2004037199A3 (en) | Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain | |
| CA2727722A1 (en) | Use of dihydroimidazolones for the treatment of anxiety in dogs | |
| HRP20020989B1 (hr) | Enantiomer 1,2-aneliranog kinolina koji inhibira farnezil transferazu | |
| PT1406859E (pt) | Derivados substituídos de 4-aminociclo-hexanol | |
| SE0000303D0 (sv) | Novel compounds | |
| EP1273301A3 (en) | Pharmaceutical preparations based on active ingredients susceptible to illict administration | |
| EP1741430A4 (en) | MEANS FOR THE TREATMENT OF PSYCHONEUROTIC DISEASES | |
| AU2002220654A1 (en) | Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders | |
| MXPA05009921A (es) | Agentes terapeuticos y/o preventivos para enfermedades cutaneas cronicas. | |
| DE60235965D1 (de) | Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz |